Correction of a pathogenic gene mutation in human embryos
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germline editing has been used for years in animals, including mice, rats, monkeys and many others, and experiments show that it can be done in both nonviable or viable human embryos as well 110-113 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [112]
In the citing paper
“Of the studies that have been conducted, the reported efficiencies of repair with templates in human embryos are very low (5,7,8).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Orthwein, A. et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science 344, 189–193 (2014)”
Cited work 10.1126/science.1248024 · retracted 2025-01-09 · notice 10.1126/science.adv1263 · this paper published 2017-08
Citations
Cites
1 retracted
Mitosis Inhibits DNA Double-Strand Break Repair to Guard Against Telomere Fusions
Orthwein, A., Fradet-Turcotte, A., Noordermeer, S. M., Canny, M. D., Brun, C. M., Strecker, J., Escribano-Diaz, C., & Durocher, D. (2014) · Science · doi:10.1126/science.1248024 · Cited by 319
RetractedA Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 601–700 of 948
Pregabalin on Hdac2 and Inpp5f levels in rats with CCI-induced neuropathic pain
Yuan, L., Li, T., Wan, Y., Liu, Y., Zhou, X., & Liu, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7037 · Cited by 4
“Mutations of Hdac2 and Inpp5f gene caused by viral infection or other autologous diseases also result in neuropathic pain (24).”
BackgroundPreimplantation genome editing: CCR5 in China
Mills, P. F. R. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190114 · Cited by 3
Dangerous Science: Science Policy and Risk Analysis for Scientists and Engineers
Rozell, D. J. (2020) · Ubiquity Press eBooks · doi:10.5334/bci · Cited by 5
Genetic testing in patients with hypertrophic cardiomyopathy
Bonaventura, J., & Veselka, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.113 · Cited by 4
“Vnitř Lék 2019; 65(10): 652–658 roku 2017 byla v časopisu Nature publikována „oprava“ zárodečné mutace v genu MYBPC3 u lidského embrya pomocí systému CRISPRCas9 s následnou indukcí endo genní DNA reparace v preimplantační diagnostice [55].”
Recent highlights and advances in cardiac gene therapy.
Oh, J. G., & Ishikawa, K. (2019) · PubMed · Cited by 4
Kim, Y. J., Lee, H., Cha, H., & Park, J. H. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0068-8 · Cited by 4
Thirty Controversies and Considerations in Hypertrophic Cardiomyopathy
Masri, A., Nazer, B., Al‐Rashdan, L., Mannello, M., Fischer, K. L., Akhavein, R., Divanji, P., Song, H. K., & Heitner, S. B. (2020) · Structural Heart · doi:10.1080/24748706.2020.1844926 · Cited by 5
Self-citationTan, Z. Y., Huang, T., & Ngeow, J. Y. Y. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0039 · Cited by 5
Transgenesis and Genome Editing in Poultry
Hwang, Y. S., & Han, J. Y. (2018) · InTech eBooks · doi:10.5772/intechopen.76961 · Cited by 6
“This system has been adopted for programmable genome editing in various organisms, including humans [4].”
BackgroundProspects and modalities for the treatment of genetic ocular anomalies
Gregory, C. Y., Wang, X., & Gregory-Evans, K. (2019) · Human Genetics · doi:10.1007/s00439-018-01968-5 · Cited by 4
“Recently, CRISPR-Cas9 technology was used to correct a pathogenic heterozygous MYBPC3 mutation in human preimplantation embryos through homology-directed repair mutation in human embryos (Ma et al. 2017).”
MethodPhillips, A. M., & Mian, S. I. (2019) · Development · doi:10.1057/s41301-019-00208-1 · Cited by 4
Development of zygotic and germline gene drives in micePreprint
Pfitzner, C., Hughes, J. N., White, M. A., Scherer, M., Piltz, S. G., & Thomas, P. (2020) · bioRxiv · doi:10.1101/2020.06.21.162594 · Cited by 5
“Further, it has recently been reported that “interhomolog repair” (effectively the same process as gene drive homing), can occur in human embryos (Ma et al. 2017), although concerns have been raised about the interpretation of these results (Egli et al.”
BackgroundResultNon-viral generation of transgenic non-human primates via the piggyBac transposon system
Nakaya, M., Iwatani, C., Tsukiyama-Fujii, S., Mieda, A., Tarumoto, S., Tsujimura, T., Yamamoto, T., Ichikawa, T., Nakamura, T., Terakado, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57365-w · Cited by 6
“During the ICSI procedure, sperm were co-injected along with the piggyBac vector and PBase mRNA 8,40 .”
Qiu, Y., Chen, Z., He, P., & Wang, Z. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1577186 · Cited by 8
Shah, W., Hussain, M., Serwat, A., Bilal, M., Raza, Y., Mansoor, A., & Faraz, A. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120875 · Cited by 5
Budgets versus Bans: How U.S. Law Restricts Germline Gene Editing
Johnston, J. (2020) · The Hastings Center Report · doi:10.1002/hast.1094 · Cited by 5
Choi, D.-K., Kim, Y.-K., HoonYu, J., Min, S., & Park, S.-W. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.020 · Cited by 5
Self-citationA precariedade humana em tempos de pandemia: meditações insólidas sobre a finitude da vida
Westphal, E. R. (2021) · Revista Brasileira de Pesquisa (Auto)Biográfica · doi:10.31892/rbpab2525-426x.2021.v6.n18.p740-756 · Cited by 3
The revolution in pharmacotherapy: from herbs to pills, moulds, antibodies to genetic tools
Lüscher, T. F. (2025) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvae098 · Cited by 3
Frozen potential: embryo research at the crossroads of ethics, regulation and scientific opportunity
Popovic, M., Scarica, C., Lopes, S. M. C. D. S., & Shahbazi, M. N. (2025) · Development · doi:10.1242/dev.205133 · Cited by 3
Tang, L., Zeng, Y., Zhou, X. W., Du, H., Li, C., Liu, J., & Zhang, P. (2018) · Molecular Reproduction and Development · doi:10.1002/mrd.22983 · Cited by 3
Novel Pharmacotherapy for Hypertrophic Cardiomyopathy
Wong, T. C., & Martinez, M. W. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2018.08.008 · Cited by 4
The Regulation of Human Germline Genome Modification in Belgium
Pennings, G. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.010 · Cited by 3
Ante-natal counseling in phacomatoses
Brabbing‐Goldstein, D., & Ben‐Shachar, S. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04776-3 · Cited by 3
CRISPR/Cas9-induced gene conversion between ATAD3 paralogs
Yanovsky‐Dagan, S., Frumkin, A., Lupski, J. R., & Harel, T. (2022) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2022.100092 · Cited by 4
Synthetic biology tools: Engineering microbes for biotechnological applications
Goyal, V., Kohli, I., Ambastha, V., Das, P., Singh, P. K., Varma, A., Pandey, R., & Joshi, N. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85577-8.00014-7 · Cited by 5
The European Court of Human Rights and the Emergence of Human Germline Genome Editing
Spaander, M. M. (2022) · European Journal of Health Law · doi:10.1163/15718093-bja10082 · Cited by 3
Critical Green Innovation Themes for Brand Development in Emerging Markets
Majeed, M. (2022) · Palgrave studies of marketing in emerging economies · doi:10.1007/978-3-030-95581-6_11 · Cited by 3
Mechanism of the CRISPR/Cas9 System Specificity in Genome Editing
Kulishova, L. M., Vokhtantsev, I. P., Kim, D. V., & Zharkov, D. O. (2023) · Molecular Biology · doi:10.31857/s0026898423020155 · Cited by 5
Self-citationLawley, C. M., & Kaski, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082788 · Cited by 6
“Finally, genetic modification in monogenic HCM is being explored; gene repair in human embryos with a pathogenic MYBPC3 variant has been shown to be feasible using a variant-specific CRISPR-Cas9 system [17], and ‘gene silencing’ techniques, initially focusing on MYH7 variant HCM and using viral vectors, are also being…”
MethodLiu, S., Yuan, P., Zheng, Y., Guo, C., Ren, Y., Weng, S., Zhang, Y., Liu, L., Xing, Z., Wang, L., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14762 · Cited by 2
“32 Besides, ‘ nucleotide excision repair ’ plays a crucial part in the damage and repair of genetic material, allowing cells to function properly, and is directly related to the mutation in genes associated with HCM. 33 In the immune in fi ltration results, the ‘ xCell ’ algorithm was utilized.”
MethodTargeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment
Stanciulescu, L. A., Dorobanţu, M., & Vatasescu, R. G. (2025) · Diagnostics · doi:10.3390/diagnostics15040420 · Cited by 3
“Advances in gene editing technologies, such as CRISPR/Cas9, offer the possibility of correcting pathogenic mutations in inherited arrhythmogenic conditions like ARVC or laminopathies, potentially reducing or even eliminating the need for invasive procedures [86,87].”
Untangling the Promises of Human Genome Editing
Drabiak, K. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518822001 · Cited by 8
Blade Runner, de 2019 a 2049. El cine de ciencia ficción como divulgador de la ciencia
Ramos, E. M. (2018) · InMediaciones de la Comunicación · doi:10.18861/ic.2018.13.2.2873 · Cited by 3
Applications of CRISPR-Cas in Ageing Research
Haston, S., Pozzi, S., & González-Meljem, J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-40955-5_11 · Cited by 5
The Skin(ny) on Regenerating the Largest Organ to Save a Patient’s Life
Yi, R. (2018) · Cell stem cell · doi:10.1016/j.stem.2017.12.005 · Cited by 3
Enhanced Beings: Human Germline Modification and the Law
Macintosh, K. L. (2018) · Scholar Commons (Santa Clara University) · Cited by 3
Editing the Genome Ex Vivo Stem Cell Therapy
Fan, Y., & Chan, J. K. Y. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0148-2 · Cited by 3
Discussion: CRISPR Craft: DNA Editing the Reconstructive Ladder
Hu, M. S.-M., Longaker, M. T., & Wan, D. C. (2018) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000004949 · Cited by 3
Prospects of Human Germline Modification by CRISPR-Cas9 – an Ethicist’s View
Birnbacher, D. (2018) · Technikzukünfte, Wissenschaft und Gesellschaft · doi:10.1007/978-3-658-22660-2_4 · Cited by 4
Fearful old world? A commentary on the Second International Summit on human genome editing
Greenfield, A. (2019) · Mammalian Genome · doi:10.1007/s00335-018-9791-2 · Cited by 7
Genom-Editierung mit CRISPR/Cas9: Vorzeichen einer neuen Epoche der Medizin?
Schermer, B., & Benzing, T. R. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0759-7180 · Cited by 4
“[12] Ma H, Marti-Gutierrez N, Park SW et al.”
BackgroundInfluentialGene therapy and regenerative tissue engineering in congenital heart disease
Nappi, F., & Sing, S. S. A. (2019) · Translational Pediatrics · doi:10.21037/tp.2019.04.10 · Cited by 3
“For example, in August, Nature published a manuscript of Shoukhrat Mitalipov that corrected a pathogenic heterozygous gene mutation MYBPC3 related to hypertrophic cardiomyopathy (1) in human embryos with precise CRISPR-Cas9 (2).”
Influential“CRISPR for Disabilities: How to Self-Regulate” or Something?
Courtright-Lim, A. (2022) · Journal of Bioethical Inquiry · doi:10.1007/s11673-021-10162-8 · Cited by 6
Preimplantation Genetic Testing
Yatsenko, S. A., & Rajkovic, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53094-1.00015-1 · Cited by 3
The Ovarian Factor in Assisted Reproductive Technology
Gleicher, N., Kushnir, V. A., & Barad, D. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00024-8 · Cited by 3
Комисаренко, С. В., & Романюк, С. И. (2020) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2020.03.050 · Cited by 3
Allele-specific genome editing using CRISPR-Cas9 causes off-target mutations in diploid yeastPreprint
de Vries, A. R. G., Couwenberg, L. G. F., van den Broek, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/397984 · Cited by 3
“However, since integration of a repair fragment and repair 403 by LOH both involve HDR (33,34), targeting heterozygous loci likely causes gene-editing efficiencies 404 and off-target mutations in other eukaryotes as well, regardless of the efficiency of NHEJ and HR.”
Running with (CRISPR) Scissors: Tool Adoption and Team Assembly
Zyontz, S. (2019) · Academy of Management Proceedings · doi:10.5465/ambpp.2019.17964abstract · Cited by 3
“3 This has already been done in non-viable human embryos (Ma et al. 2017) and may have been done in viable embryos resulting in gene edited babies as recently as November 2018 (Cyranoski 2018).”
BackgroundMethodIntergenerational pathogen-induced diapause in C. elegans is modulated by mir-243Preprint
Gabaldón, C., Legüe, M., Palominos, M. F., Verdugo, L., Gutzwiller, F., & Calixto, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.31.019349 · Cited by 3
“Likewise, mir288 67 mutants exhibited reduced pathogen avoidance behavior, apparently due to a dysregulation in sax-7 289 targeting (44, 45).”
BackgroundTreatment of a metabolic liver disease by in vivo prime editing in micePreprint
Böck, D., Rothgangl, T., Villiger, L., Schmidheini, L., Mathis, N., Ioannidi, E. I., Kreutzer, S., Kontarakis, Z., Rimann, N., Grisch‐Chan, H. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.17.456632 · Cited by 3
SANALKUMAR, V. R. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/bce2n · Cited by 3
Maron, B. J., Maron, M. S., & Rowin, E. J. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100922 · Cited by 4
Geuverink, W. P., der Wal, J. T. G.-V., Cornel, M. C., Peerbolte, L. J. L., Prinds, C., van El, C. G., & Martin, L. (2024) · Humanities and Social Sciences Communications · doi:10.1057/s41599-024-03576-3 · Cited by 2
“Currently, studies using GGE on human embryos are already in progress (Li et al., 2019; Ma et al., 2017; Zeng et al., 2018; Zhang et al., 2019).”
Qiu, J. (2025) · The CRISPR Journal · doi:10.1089/crispr.2025.0057 · Cited by 2
Charlier, J., Sherkatghanad, Z., & Makarenkov, V. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013606 · Cited by 3
Integrating synthetic biology to understand and engineer the heart, lung, blood, and sleep systems
Chaikof, E. L., Chen, J., Gillette, M. U., Boyer, L. A., Deans, T. L., Li, P., Hilton, I. B., Daniels, K. G., Goyal, Y., Mei, Y., et al. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101446 · Cited by 2
Nucleic acid based therapies: developing frontier for precision medicine
Pirmohamed, M. (2018) · BMJ · doi:10.1136/bmj.k223 · Cited by 2
Point: Treating Human Genetic Disease One Base Pair at a Time: The Benefits of Gene Editing
Katsanis, N. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.278309 · Cited by 2
A rocky road for the maturation of embryo-editing methods
Marx, V. (2019) · Nature Methods · doi:10.1038/s41592-018-0307-5 · Cited by 2
Stammzellforschung: Aktuelle wissenschaftliche und gesellschaftliche Entwicklungen
Zenke, M., Marx-Stölting, L., Schickl, H., & Verlagsgesellschaft, N. (2018) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783845287720 · Cited by 7
Комісаренко, С. В., & Романюк, С. И. (2021) · The Ukrainian Biochemical Journal · doi:10.15407/ubj93.01.113 · Cited by 3
Genomic Editing, Human Enhancement, and Transhumanism: A Brief Overview
Pavelić, K., & Pavelić, S. K. (2022) · Donald School Journal of Ultrasound in Obstetrics & Gynecology · doi:10.5005/jp-journals-10009-1934 · Cited by 1
Spaander, M. M. (2023) · Brill | Nijhoff eBooks · doi:10.1163/9789004526136_008 · Cited by 2
Szocik, K. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197628478.003.0003 · Cited by 2
Recent advances in CRISPR-Cas system for the treatment of genetic hearing loss.
Yin, G., Wang, X., & Sun, Y. (2023) · PubMed Central · Cited by 9
Benefits of using the CRISPR-Cas9 system in the modification of genetic disorders
Ахнафович, Ш. Р., Абдурахманович, О. М., Рамильевич, М. А., Dybova, A. I., Vyaseleva, E. T., Kayumova, N. B., Saitgalina, A. S., Ententeev, K. R., Ягафаров, И. Р., Kuserbaev, I. V., et al. (2023) · Molecular Genetics Microbiology and Virology (Russian) · doi:10.17116/molgen2023410313 · Cited by 2
Gene editing and therapy in acquired and inherited cardiovascular disorders
Duddu, S., Chakrabarti, R., Sharma, P., Gupta, D., & Shukla, P. C. (2024) · The Nucleus · doi:10.1007/s13237-024-00480-8 · Cited by 3
Allele conversion between homologous chromosomes via CRISPR-Cas9 and hyperrecombination lines
Zhang, X., Chen, Y. J., Liu, Z., et al. (2024) · Plant Communications · doi:10.1016/j.xplc.2024.101233 · Cited by 2
“However, studies in tomato and Arabidopsis reported gene conversion events in only a very small fraction of tissue cells and none of the whole plants in the F 1 generation, indicating a very low efficiency of CRISPR-Cas9-mediated conversion in non-HRL plants (Filler Hayut et al., 2017; Filler-Hayut et al., 2021).”
Discussions on Human Enhancement Meet Science: A Quantitative Analysis
Żuradzki, T., Bystranowski, P., & Dranseika, V. (2025) · Science and Engineering Ethics · doi:10.1007/s11948-025-00531-6 · Cited by 5
“20 Here are paradigmatic examples: Ma et al. (2017), who corrected the heterozygous MYBPC3 mutation in human preimplantation embryos with the CRISPR–Cas9 tool, is a typical empirical bioscience paper; Dreu et al. (2011), who measured the behavioral effects (ethnocentrism) of a peptide hormone…”
Interallelic gene conversion of leukemia-associated single nucleotide variants
Silver, A. J., Brown, D. J., Olmstead, S. D., Watke, J., Gorska, A. E., Tanner, L., Ramsey, H. E., & Savona, M. R. (2025) · Gene · doi:10.1016/j.gene.2025.149493 · Cited by 4
Rafiq, S., & Assad, A. (2025) · Journal of Computational Biology · doi:10.1089/cmb.2025.0031 · Cited by 2
“This technology has applications in personalized medicine, including correcting genetic mutations in human embryos (Ma et al., 2017).”
The Regulation of Human Germline Genome Modification in the Republic of Korea
Kim, H. H., & Joly, Y. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108759083.019 · Cited by 2
A Bibliometric Analysis of Research on CRISPR in Social Sciences and Humanities
Asquer, A., & Krachkovskaya, I. (2021) · Re GEN Open · doi:10.1089/regen.2021.0007 · Cited by 2
“1 Bioethics (8) Genetic Engineering and Biotechnology News (54) American Journal of Bioethics (77) 2 Biology & Philosophy (8) International Journal of Biological Macromolecules (28) Frontiers in Genetics (37) 3 Science and Engineering Ethics (8) Biology and Philosophy (8) Bioethics (32) 4 American Journal of Bioethics…”
Benyahia, B., Brumano, L. P., Pessoa, A., & da Silva, F. V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-444-64301-8.00002-0 · Cited by 2
Human genome editing in heart disease
Lim, G. B. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.128 · Cited by 2
Human genome editing in heart disease
Lim, G. B. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.69 · Cited by 2
Striking a Balance: Policy Considerations for Human Germline Modification
Seitz, J. D. (2018) · Santa Clara Law Digital Commons (Santa Clara University) · Cited by 2
On the Road from Gene to Therapy in Inherited Cardiomyopathies
Limongelli, G., Bossone, E., Elliot, P. M., & Day, S. M. (2018) · Heart Failure Clinics · doi:10.1016/j.hfc.2018.01.003 · Cited by 2
CRISPR/Cas9 Gene Editing and its Potential to Treat Common Diseases
Bonner, A. B. (2018) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2018.05.0001142 · Cited by 2
“These ethical debates will grow as CRISPR technology becomes more applicable to altering the genetic makeup of embryos [24].”
BackgroundBetween Moral Hazard and Legal Uncertainty: An Introduction
Braun, M., Schickl, H., & Dabrock, P. (2018) · Technikzukünfte, Wissenschaft und Gesellschaft · doi:10.1007/978-3-658-22660-2_1 · Cited by 4
Impact of genetic studies on comprehension and treatment of congenital heart disease
Alicandro, T., Putotto, C., Calcagni, G., Unolt, M., Mastromoro, G., Digilio, M. C., Versacci, P., & Marino, B. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.10.003 · Cited by 2
Human germline editing: Insights to future clinical treatment of diseases
Li, Y., Kang, X., Pang, J. K. S., Soh, B.-S., Yu, Y., & Fan, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0594-8 · Cited by 2
Self-citationChallenges and Future in Precision Cardiovascular Medicine
Baek, S. H. (2019) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2019.1.e3 · Cited by 2
Advances in Developmental Genetics and Achievements in Assisted Reproductive Technology
Баранов, В. С., Kogan, I. Y., & Kuznetzova, T. V. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419100028 · Cited by 3
Wang, X. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/729/1/012044 · Cited by 3
Prenatal Diagnosis and Preimplantation Genetic Testing for Inherited Cardiac Diseases
Nannenberg, E. A., & Arens, Y. H. J. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_27 · Cited by 2
CRISPR/Cas9 Editing in Induced Pluripotent Stem Cells: A Way Forward for Treating Cystic Fibrosis?
Quiroz, E. J., & Ryan, A. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-29403-8_9 · Cited by 3
Kidney Regenerative Medicine: Promises and Limitations
Frank, C. N., & Petrosyan, A. (2020) · Current Transplantation Reports · doi:10.1007/s40472-020-00273-3 · Cited by 2
World Ships: Feasibility and RationalePreprint
Hein, A. M., Smith, C. M., Marin, F., & Staats, K. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2005.04100 · Cited by 6
“one of these modes [51].”
Genetic Analysis of the Embryo: Preimplantation Genetic Diagnosis
Thornhill, A. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64861-4 · Cited by 2
Combining Crowdsourcing and Deep Learning to Assess Public Opinion on CRISPR-Cas9Preprint
Müller, M., Schneider, M., Salathé, M., & Vayena, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/802454 · Cited by 2
“Peak c coincides with the publication of a study which reported the correction of a mutation in human embryos [42], causing widespread media attention and, as before, did not cause a drop in sentiment.”
ResultCorrecting reference bias from the Illumina Isaac aligner enables analysis of cancer genomesPreprint
Cornish, A. J., Chubb, D., Frangou, A., Hoang, P. H., Kaiser, M., Wedge, D. C., & Houlston, R. S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/836171 · Cited by 2
“…cancer-sequencing studies (Burns et al., 2018; Quigley et al., 2018; Ross-Innes et al., 2015), to evaluate genome editing and characterise off-target effects (Kim et al., 2015; Kim et al., 2017; Ma et al., 2017), and in the validation of embryo screening techniques (Fiorentino et al., 2014).”
BackgroundChen, S., Guo, Z., Ye, Y., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03155-1 · Cited by 1
“Considering that this disease is caused by SEC23B gene mutations, genetic correction by the clustered regularly interspaced short palindromic repeats (CRISPR) technique is expected to be used for the early diagnosis and treatment of this disease in the future [17].”
BackgroundParanal, R. M., Teekakirikul, P., Ho, C. Y., Fatkin, D., & Seidman, C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00002-1 · Cited by 4
Nestor, M. W., & Wilson, R. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98368-0_5 · Cited by 1
The Ethical Concerns of CRISPR Editing in Embryos
Pydipati, B. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.5121 · Cited by 1
Briski, O., Cabeza, J. P., Salamone, D., Fernández-Martín, R., & Gambini, A. (2024) · Reproduction Fertility and Development · doi:10.1071/rd24129 · Cited by 1
A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy
Dong, J., Liu, M., Chen, Q., & Zha, L. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s505865 · Cited by 1
The potential of CRISPR-Cas9 in cardiovascular medicine: a focus on hereditary cardiomyopathies
Rasheed, S., Jha, M., Waheed, A., Farooq, U., Fatima, A., Haq, I. U., Khan, U., Wardak, A. B., & Gul, M. H. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003170 · Cited by 1
Metadata
- Authors
- Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., Darby, H., Van Dyken, C., Li, Y., Kang, E., Park, A.-R., Kim, D., Kim, S.-T., Gong, J., Gu, Y., Xu, X., Battaglia, D., Krieg, S. A., Lee, D. M., Wu, D. H., Wolf, D. P., Heitner, S. B., Belmonte, J. C. I., Amato, P., Kim, J.-S., Kaul, S., & Mitalipov, S.
- Affiliations
- Oregon Health & Science University (US)
- Institute for Basic Science (KR)
- Salk Institute for Biological Studies (US)
- Seoul National University (KR)
- BGI Group (China) (CN)
- Corresponding author
- Amato, Paula
- Kim, Jin-Soo
- Kaul, Sanjiv
- Mitalipov, Shoukhrat
- ORCID
- Venue
- Nature
- Published
- 2017-08
- Volume
- 548
- Issue
- 7668
- Pages
- 413-419
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2740810575
- Cited by
- 992
- References
- 48
- Citations by year
- 2026: 22 · 2025: 50 · 2024: 47 · 2023: 93 · 2022: 75 · 2021: 107 · 2020: 135 · 2019: 155 · 2018: 217 · 2017: 88
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2017-10-02)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- Oregon Health and Science University
- Leona M. and Harry B. Helmsley Charitable Trust
- Consorzio Interuniversitario Biotecnologie
- Moxie Foundation
- Government of Jiangxi Province
- Institute for Basic Science (IBSR021-D1, R021-D1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- germline editing, CRISPR/Cas9, MYBPC3 mutation, hypertrophic cardiomyopathy, preimplantation embryo, homology-directed repair, mosaicism, DNA double-strand break repair, cell cycle timing, preimplantation genetic diagnosis, off-target mutations
- MeSH terms
- Gene Editing, Myosin Binding Protein C, Adult, Alleles, Blastocyst, Carrier Proteins, Cell Division, Embryo, Mammalian, Genetic Complementation Test, Heterozygote, Homozygote, Humans, Male, Mosaicism, Mutation, Templates, Genetic, Zygote, S Phase, Gene Targeting, DNA Breaks, Double-Stranded, Recombinational DNA Repair, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.